相关实验视频
Updated: Sep 13, 2025

07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
33.5K
托西菲林作为一般患者的辅助疗法,用芬伊托因治疗:一项随机对照研究
Maha A Younis1, Sahar M El-Haggar2, Wessam Mustafa3
1Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, 34518, Egypt. myounis@horus.edu.eg.
Molecular neurobiology
|July 31, 2025
概括
托西菲林 (PTX) 作为一般性的补充治疗有前途. 这项研究发现,PTX显著降低了神经炎症标志物,并改善了患者的认知功能和生活质量.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种慢性神经系统疾病,影响着全世界数以百万计的人.
- 神经炎症在发生过程中起着至关重要的作用.
- 临床前研究表明,西菲林 (PTX) 在模型中具有保护作用.
研究的目的:
- 调查pentoxifylline在一般性患者中的作用和保护机制.
- 评估托西菲林对神经炎症标志物和临床结果的影响.
主要方法:
- 一项受控的并行随机临床研究,涉及66名泛性患者.
- 患者接受了单独的氨酸 (对照剂) 或氨酸加氧fylline 6 个月.
- 评估了HMGB-1,TLR-4,NF-κB,Aβ和Nrf2的血清水平,以及MMSE,QOLIE-31分数和发作频率.
主要成果:
- 托西菲林组显示HMGB1,TLR-4,NF-κB和Aβ水平显著降低.
- 在pentoxifylline组中观察到血清Nrf2水平的显著增加.
- 接受pentoxifylline治疗的患者在MMSE和QOLIE-31得分上显著改善,并减少了发作频率.
结论:
- 托西菲林在一般性患者中表现出显著的抗炎作用.
- 托西菲林改善了认知功能,生活质量和控制.
- 托克西菲林可能是一般性的有益辅助疗法.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278
Antiepileptic Drugs: GABAergic Pathway Potentiators
653
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
653
Antiepileptic Drugs: Glutamate Antagonists
517
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
517
Antiepileptic Drugs: Sodium Channel Blockers
890
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
890
Antiepileptic Drugs: Calcium Channel Blockers
632
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
632
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
451
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
451

